𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration

✍ Scribed by J. Dieter Nagel; Freek J. Varossieau; Ria Dubbelman; Wim W. Bokkel Huinink; J. Gordon McVie


Publisher
Springer
Year
1992
Tongue
English
Weight
470 KB
Volume
29
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetics of carboplatin after in
✍ F. Elferink; W. J. F. Vijgh; I. Klein; W. W. Bokkel Huinink; R. Dubbelman; J. G. πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 455 KB

The pharmacokinetics of carboplatin, ultrafilterable platinum, and total platinum after intraperitoneal (i.p.) administration were studied in peritoneal fluid, plasma, red blood cells (RBCs), and urine during a phase-I trial in patients with minimal, residual ovarian cancer. Samples were collected f

Clinical pharmacokinetics of procaterol:
✍ Dr Michael A. Eldon; Debbie S. Blake; Michael J. Coon; Gerald D. Nordblom; Allen πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 2 views

Procaterol is a potent, orally active &-agonist bronchodilator useful in the treatment of reversible bronchospastic disease. It is effective when administered as single or multiple (Q8H) 50 and 75pg doses. As part of the clinical development of procaterol, the pharmacokinetics and dose proportionali